GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, amongst other routine matters.